France proposes to classify CBD as «toxic» at European level
According to information tracked by CosmeticOBS, France's intention to classify CBD as toxic at European level is now an official proposal.
If the process is completed, CBD will be banned from cosmetic products in Europe, with implications for other types of product that are difficult to gauge.
What happened?
In June 2023, France announced its intention to ban the use of cannabidiol (CBD) in cosmetic products in Europe.
The idea was to classify CBD as CMR, i.e. Carcinogenic, Mutagenic and toxic for Reproduction, and therefore prohibited in cosmetic products in Europe.
As we explained at the time, the CBD is in the CosIng, is the European database of all cosmetic ingredients approved in Europe, for anti-sebum, antioxidant, moisturizing and skin-protecting uses, but is not regulated by Cosmetic Regulation 1223/2009 on cosmetic substances and ingredients.
In 2023, the European Commission launched a call for data with the aim of preparing a mandate for the work of a Scientific Committee (CSSC). The latter should soon have to rule on the safety of CBD, taking into account the possible unintentional presence, in trace amounts, of other substances. cannabinoids, including THC.
France's position is to ban it for its alleged «reprotoxic» nature, a proposal published on September 11 by the European Chemicals Agency (ECHA). If CBD is listed as toxic for reproduction, it will be banned in cosmetic products in Europe, unless exempted from the ban following an opinion from the SCCS, says CosmeticOBS.
And from our understanding, would open the door to further prohibitions.
-
Cannabis in France4 weeks ago
France Sets July as the Deadline for the Widespread Adoption of Medical Cannabis
-
Cannabis in Europe2 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France2 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in the U.S.2 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Cannabis in Ireland3 weeks ago
The Irish Parliament recommends decriminalizing all drugs
-
Business4 weeks ago
Sanity Group is expanding its presence in Switzerland through a distribution agreement with Astrasana
-
Cannabis in France4 weeks ago
50th Anniversary of the ’Call of the 18th Joint«: What’s in Store?
-
Cannabis in France4 weeks ago
Medical Cannabis in France: What the First Major Study Reveals About Its Actual Impact


FARID GHEHIOUECHE
September 18, 2024 at 18 h 45 min
Once again, France is playing a harmful role, and once again, Europe will be accused of being an instrument at the service of industry lobbies.
We need to get away from this regulatory madness that allows the use of glyphosate, but now claims to ban cannabidiol.
NotFrenchForever
September 25, 2024 at 11 h 26 min
It's truly pitiful to dedicate your life to politics and yet choose to hinder progress rather than implement it.